Cite

HARVARD Citation

    Lee, S. et al. (2022). Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer. Thoracic cancer. 13 (3), pp. 380-385. [Online]. 
  
Back to record